Precision Diagnostics, Accelerated: GenScript's Portfolio for Modern IVD Innovation

Next-generation molecular diagnostics are transforming disease detection, monitoring, and treatment strategies, propelling us into a new era of precision medicine. Whether identifying clinically relevant genetic mutations or enabling tailored treatment approaches through companion diagnostics, developers face growing pressure to create assays that are both robust and rapidly deployable. Recently, CRISPR technology has been found to be a useful tool for the development of highly specific and sensitive, novel diagnostics tests.

In this session, we'll examine how GenScript's integrated IVD solutions can streamline your diagnostic development pipeline—from gene synthesis and CRISPR-based tools to custom antibody development and recombinant protein production. Join us to discuss practical approaches to common development bottlenecks and see how our technical expertise can support your innovations in biomarker discovery and companion diagnostic development.